Related Experiment Videos
[Pathogenesis of type 2 diabetes mellitus]
P-J Guillausseau1, M Laloi-Michelin
1Service de médecine interne B, hôpital Lariboisière, 2, rue Ambroise-Paré, 75475 Paris 10, France. pierre-jean.guillausseau@lrb.ap-hop-paris.fr
Summary
Type 2 diabetes mellitus is a multifactorial disease driven by insulin resistance and beta-cell dysfunction. Lifestyle changes and targeted therapies can manage hyperglycemia and prevent disease progression.
Area of Science:
- Endocrinology and Metabolism
- Molecular Biology
- Genetics
Context:
- Type 2 diabetes mellitus (T2DM) is a complex endocrine disorder characterized by hyperglycemia.
- Pathophysiology involves decreased insulin secretion and impaired insulin sensitivity, leading to reduced glucose uptake and increased hepatic glucose production.
- Genetic predisposition and Western lifestyle factors, including obesity and physical inactivity, contribute to T2DM development.
Purpose:
- To elucidate the intricate interplay between beta-cell dysfunction and insulin resistance in T2DM.
- To understand the mechanisms of beta-cell compensation failure in genetically predisposed individuals.
- To explore therapeutic strategies targeting metabolic defects in T2DM.
Summary:
- T2DM involves multifactorial defects, including reduced insulin secretion and peripheral insulin resistance.
- Beta-cell dysfunction, characterized by various secretory abnormalities, contributes to hyperglycemia.
- Failure of beta-cells to compensate for insulin resistance leads to progressive glucose elevation and overt T2DM, exacerbated by glucotoxicity and lipotoxicity.
Impact:
- Lifestyle modifications, such as regular physical activity and weight management, are crucial for preventing T2DM.
- Pharmacological interventions targeting insulin secretagogues, sensitizers, and hepatic glucose production are vital for managing hyperglycemia in T2DM patients.
- Improved understanding of T2DM pathogenesis facilitates the development of effective prevention and treatment strategies.